Newer indications of tranexamic acid in dermatology beyond melasma: a review
Tranexamic acid (TXA) is an antifibrinolytic agent approved for use to control bleeding during surgery and after trauma. It has been used in dermatology as a therapeutic and prophylactic agent in angioedema since 1970s but its recently discovered role in melasma has made it the current molecule of i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Pigment International |
| Subjects: | |
| Online Access: | http://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2022;volume=9;issue=2;spage=70;epage=81;aulast=Arora |